SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Otonomy, Inc. (OTIC)

OTIC RSS Feed
Add OTIC Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 8/8/2016 12:26:39 PM - Followers: 6 - Board type: Free - Posts Today: 0
Otonomy, Inc (OTIC) 
 
 
Company website
 

 
Company Address:
6275 Nancy Ridge Drive
Suite 100
San Diego, CA 92121
United States - Map
Phone: 858-242-5200
Fax: 858-200-0933

 
Otonomy, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for the treatment of diseases and disorders of the ear. To overcome many of the limitations of delivering drugs to the middle and inner ear, we have developed a proprietary technology that is designed to deliver drug that is retained in the ear for an extended period of time following a single local administration, which we refer to as “sustained-exposure.” Utilizing this technology, we have advanced three product candidates into development: AuriPro, OTO-104 and OTO-311. Our lead product candidate, AuriPro, is a sustained-exposure antibiotic that has completed two identical Phase 3 clinical trials in a total of 532 pediatric patients with middle ear effusion at the time of tympanostomy tube placement surgery. Top-line results of these Phase 3 trials demonstrated that AuriPro achieved the primary efficacy endpoint with statistical significance (p<0.001) and was well tolerated. Our second product candidate, OTO-104, is a sustained-exposure steroid in a Phase 2b clinical trial for patients with Ménière’s disease. Our third product candidate, OTO-311, is in preclinical development as a treatment for tinnitus. There are no drugs approved by the FDA for the lead indications we are currently pursuing for our product candidates.
 
Management
 
Pipeline
 
Yahoo Headlines
 
Seeking Alpha
 
Press Releases
 
SEC Filings
 
Share Structure:  See SEC filings
 
Investor Relations:  ir@otonomy.com
 
 
 

 
 
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 
 
 
 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
OTIC
Current Price
Volume:
Bid Ask Day's Range
SureTrader
OTIC News: Otonomy Successfully Completes Open-Label Clinical Trial for OTIPRIO® in Patients with History of Otitis Media Requiring Ty... 09/15/2016 07:30:00 AM
OTIC News: Otonomy Announces OTIPRIO® Data Presentation and Symposium at American Academy of Otolaryngology - Head and Neck Surgery Fou... 09/13/2016 07:30:00 AM
OTIC News: Statement of Changes in Beneficial Ownership (4) 09/08/2016 06:56:35 PM
OTIC News: Otonomy to Present at Baird Global Healthcare Conference 09/01/2016 07:30:00 AM
OTIC News: Otonomy Reports Second Quarter 2016 Financial Results and Provides Corporate Update 08/04/2016 04:09:49 PM
PostSubject
#14   8/8/2016 Piper Jaffray Cos. Reiterated Rating Overweight $42.00 -> $32.00 realfast95 08/08/16 12:26:39 PM
#13   OTIC bullish 16.08 stocktrademan 06/05/16 12:49:30 PM
#12   pow, too the moon alice, to the moon realfast95 06/01/16 10:34:38 AM
#11   Otonomy OTIC WallachBeth Buy $29 realfast95 05/26/16 10:28:19 AM
#10   events - this weekend realfast95 05/21/16 09:51:46 AM
#9   Lets look at the charts realfast95 05/21/16 09:41:23 AM
#8   Otonomy Announces Assignment of C Code and Pass-Through realfast95 05/20/16 09:58:28 AM
#7   $OTIC Otonomy Announces Assignment of C Code and realfast95 05/20/16 08:52:09 AM
#6   j code hearing May 18th realfast95 05/18/16 06:56:55 PM
#5   $OTIC recent news/filings stocktrademan 12/18/15 02:37:48 PM
#4   Two Stocks to Watch This Month in Biotech trendmkr 12/03/15 01:25:39 PM
#3   $OTIC recent news/filings stocktrademan 11/25/15 02:22:56 PM
#2   $OTIC 6 month Chart KarinCA 01/18/15 11:23:07 AM
#1   Yahoo Headlines: KarinCA 12/27/14 12:29:43 AM
PostSubject